Latest News about NVS

Recent news which mentions NVS

...

21 22 23 24 25 26 27 28 Next >

EMA's Advisory Committee Backs Approval Of Incyte's Capmatinib In Advanced Lung Cancer Setting

April 22, 2022

FDA Puts Blood Cancer Nods Under Scrutiny On Substantial Toxicity Profile Of PI3K Drugs

April 21, 2022

7 Potential Biotech Stocks Buyout Targets in 2022

April 21, 2022

3 Fantastic Biotech Stocks to Buy in April

April 18, 2022

Golden Cross Appears Before Novartis Investors

April 14, 2022

Hopeful Golden Cross Forms On Novartis's Chart

April 14, 2022

2 Unstoppable Green Flags for AbbVie

April 14, 2022

Biogen’s Aduhelm Crashes the Biotech Sector

April 13, 2022

The Daily Biotech Pulse: Aeglea Stock Jumps On Inherited Metabolic Disease Data, Partial Hold Lifted On Gilead's 2 Blood Trials, Early Data From Novartis' KRAS Inhibitor And More

April 12, 2022

Attacking Diseases On Multiple Fronts — Pharmaceutical Development Combined With Cannabis?

April 12, 2022

Overview Of Value Stocks In The Healthcare Sector

April 11, 2022

The Week Ahead In Biotech (April 10-April 16): Regeneron FDA Decision, Cancer Conference Presentations And More

April 10, 2022

3 Things About Pfizer That Smart Investors Know

April 08, 2022

Layoffs at Bluebird Bio Highlight the Current Struggles of Biotech Picks

April 08, 2022

Novartis' Breast Cancer PI3K Drug, Scores FDA Approval For Ultra-Rare Indication

April 06, 2022

The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy

April 06, 2022

Novartis Highlights Four-Year Efficacy, Safety Data On Kesimpta In Multiple Sclerosis

April 05, 2022

The Daily Biotech Pulse: Thervance Gains On Positive Late-Stage Readout, Bristol-Myers Squibb Snags 3 Approvals In Europe, Decision Day For BioXcel

April 05, 2022

7 Biotech Stocks to Buy With Key Catalysts for April

April 05, 2022

Morning Brief: Top Stories Dominating Financial Media on Monday, April 4

April 04, 2022

Novartis To Strengthen Pipeline, Boost Productivity With New Organizational Structure

April 04, 2022

3 CEOs to Invest In

April 01, 2022

Attention Biotech Investors: Mark Your Calendar For April PDUFA Dates

April 01, 2022

Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs

March 28, 2022

The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More

March 27, 2022

Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.

March 27, 2022

Novartis Receives Positive CHMP Opinion For Kymriah In Follicular Lymphoma, Jakavi In GvHD

March 25, 2022

2 Healthcare Stocks You Can Buy and Hold for the Next Decade

March 24, 2022

This Biotech Company Looks To Be Targeting A New Drug To Treat NASH, The Leading Cause of Liver Transplants

March 24, 2022

FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer

March 24, 2022

...

21 22 23 24 25 26 27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.